CHI to Celebrate the 10th Anniversary of PEGS - the essential protein & antibody engineering summit
Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
Over 1,600 participants will gather in Boston’s historic Seaport District for open forum discussions and collaboration in the areas of protein & antibody engineering, oncology, expression, analytical, safety, and - new this year- bioprocessing and therapeutics programming. The continued success of PEGS is driven by the growth in biologics worldwide, the quality of scientific programming presented and valuable networking opportunities.
A plenary keynote session will kick off the week with presentations from industry leaders Bahija Jallal, Ph.D., Executive Vice President of MedImmune, and George D. Yancopoulos, M.D., Ph.D., President, Regeneron Laboratories;
The summit will offer over 375 presentations within 7 topic-focused streams comprised of 20 conferences, 17 short courses, over 100 exhibiting companies, and nearly 200 scientific research posters on display. Delegates can create their own agenda by moving between the tracks and choosing the sessions that best fit their research and networking needs.
Tools and Winning Strategies for Creating the Next Generation of Biologics
Lessons Learned from Recent Challenges & Advances in Antibody Therapeutics
Advancing Development of Biologics through Novel Targets and Constructs
Meeting the Challenge to Improve Throughput and Quality
Overcoming Challenges in Characterization, Biophysical Analysis and Aggregation
Immunogenicity Assays, PK/PD and Control of Immunogenicity for Safety and Efficacy
Ensuring Effective and Efficient Scale-Up and Production of Antibody-Based Biologics
Exhibit and sponsorship opportunities are available. For details, contact Carol Dinerstein, 781-972-5471, firstname.lastname@example.org.
Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, email@example.com.
For more information, visit http://www.PEGSummit.com.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group. For more information, visit http://www.chicorporate.com.
For more information:
Cambridge Healthtech Institute